Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Waterloo

$25,000.00

An innovative new micro-CT system: Proof-of-principle in biomedical imaging of atherosclerosis

FY 2018-19

Summary
Micro-computed-tomography (m-CT) scanners can take pictures inside the body non-invasively. Knowing*what changes happen in progressive disease conditions like obesity, cancer, and heart disease, and when and*how they start to become really dangerous to the body, is critical for effectively diagnosing people and*targeting treatments. Most of the research that leads to these discoveries is done in mice that have the same*organ systems as humans, and develop many of the same diseases. Having a tool that would allow scientists to*capture detailed images inside mice at different stages of disease development would provide a huge amount of*new information, and accelerate disease research in multiple fields. Currently, there are some tools that can do*this - but they aren't widely used, for several reasons: 1) They cost too much for most labs to afford. 2) They*use very high levels of radiation that damage DNA, causing mutations that disrupt the research. 3) They*produce low-resolution pictures, which don't provide enough detail for studying things like hardening of the*arteries, or cancer cell invasion. To solve these problems, engineers at the Canadian company KA Imaging*built an innovative new m-CT scanner that takes super-high-resolution pictures, uses only low-dose radiation,*and can be made in Canada for a fraction of the cost of current m-CT systems. However, before researchers,*and eventually doctors, will use it, it needs to be optimized and validated. However, Engineers don't have the*expertise to know what cells and tissues should look like. In this work, Engineers will work with Biomedical*researchers to take pictures and analyze artery plaques from mice in both traditional ways, and using the new*m-CT. This will help to operationalize the innovative new m-CT system, as a necessary step in*commercialization. Outcomes will benefit Canada's image as a leader in medical technology, and will help*provide a cost-effective tool that will be made-in-Canada, providing high-tech jobs, and revolutionizing*medical research and diagnostic capabilities globally.
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
523522-2018
Name nom
Duncan, Robin
Department département
Kinesiology
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Partie
1
Nb partie
1
Application title
An innovative new micro-CT system: Proof-of-principle in biomedical imaging of atherosclerosis
Keyword
NSERC
Application summary
Micro-computed-tomography (m-CT) scanners can take pictures inside the body non-invasively. Knowing*what changes happen in progressive disease conditions like obesity, cancer, and heart disease, and when and*how they start to become really dangerous to the body, is critical for effectively diagnosing people and*targeting treatments. Most of the research that leads to these discoveries is done in mice that have the same*organ systems as humans, and develop many of the same diseases. Having a tool that would allow scientists to*capture detailed images inside mice at different stages of disease development would provide a huge amount of*new information, and accelerate disease research in multiple fields. Currently, there are some tools that can do*this - but they aren't widely used, for several reasons: 1) They cost too much for most labs to afford. 2) They*use very high levels of radiation that damage DNA, causing mutations that disrupt the research. 3) They*produce low-resolution pictures, which don't provide enough detail for studying things like hardening of the*arteries, or cancer cell invasion. To solve these problems, engineers at the Canadian company KA Imaging*built an innovative new m-CT scanner that takes super-high-resolution pictures, uses only low-dose radiation,*and can be made in Canada for a fraction of the cost of current m-CT systems. However, before researchers,*and eventually doctors, will use it, it needs to be optimized and validated. However, Engineers don't have the*expertise to know what cells and tissues should look like. In this work, Engineers will work with Biomedical*researchers to take pictures and analyze artery plaques from mice in both traditional ways, and using the new*m-CT. This will help to operationalize the innovative new m-CT system, as a necessary step in*commercialization. Outcomes will benefit Canada's image as a leader in medical technology, and will help*provide a cost-effective tool that will be made-in-Canada, providing high-tech jobs, and revolutionizing*medical research and diagnostic capabilities globally.